Early, short-term outcomes confirm that TRIUMPH is achieving its desired goals: attracting and preparing medical students to work with urban underserved communities. The program serves as a model to prepare physicians to meet the needs of urban HPSAs.

Centered Research and Reviews (JPCRR) is a peer-reviewed scientific journal whose mission is to communicate clinical and bench research findings, with the goal of improving the quality of human health, the care of the individual patient, and the care of populations.

In 1957, two game theorists wrote, "In all of man's written record there has been a preoccupation with conflict of interest; possibly only the topics of God, love, and inner struggle have received comparable attention." 1 However, conflicts of interestthe problem of how to align competing interests-was not considered from the policy perspective until the 1960s. In this issue of the Journal of Clinical Oncology, Parascandola 2 shares a fascinating historical case study of the first conflicts of interest policy at National Academy of Sciences. A fundamental debate in this case was whether one can simply declare a financial interest or whether one must admit that this financial interest is a potential source of bias.Real or perceived threats to research integrity depend, to some extent, on funding sources. In the early 20th century, research was supported by private resources. By 1960, the government supported more than 60% of scientific research. 2 Since then, collaboration between industry and academia has increased dramatically. In 1980, the Bayh-Dole Act passed, resulting in the watershed moment that stimulated private-public partnership. This act allowed private entities to patent products of governmentsponsored research. 3 Today, the leading funder of medical research and education is the pharmaceutical industry. 4,5 Public concern about conflicts of interest has paralleled this changing funding dynamic. Early conflicts of interest policies were focused on federally funded university research. Society was increasingly concerned about potential for government and special interests to shape unfairly the research agenda and compromise researchers' objectivity and credibility. In the 1970s, public attention shifted to environmental researchers' ties to the radiation, tobacco, chemical pesticides, and food additives industries. 2 As biomedical research has increased during the last 10 to 15 years, public attention has moved to potential conflicts of interest in pharmaceutical industry-sponsored clinical research.What is at stake? The only way to conquer cancer is to develop effective preventive and treatment strategies that the public trusts. However, financial incentives often spur drug development. 6,7 As a result, new discoveries are made with the financial and intellectual help of commercial entities. 5,7 Many